ARCA biopharma's competitors

ARCA biopharma's competitors include Intellia Therapeutics, Bioblast Pharma, Vical and Aevi Genomic Medicine
Add company...
ARCA biopharma
ARCA biopharma develops genetically-targeted therapies for cardiovascular diseases.
Intellia Therapeutics
Intellia is developing therapeutic products to help people with genetic diseases.
Bioblast Pharma
Bioblast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases.
Vical
Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.
Aevi Genomic Medicine
Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.
Founding Date
Founding Date
2009
Founding Date
2014
Founding Date
2012
Founding Date
1987
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Westminster, US HQ
Aurora, US
Westminster, US
Locations
Cambridge, US HQ
Locations
Tel Aviv-Yafo, IL HQ
Locations
San Diego, US HQ
Locations
Wayne, US HQ
San Francisco, US
Employees
Employees
20
Employees
10470% increase
Employees
12
Employees
73
Employees
24
Valuation ($)
Valuation ($)
8.8 m
Valuation ($)
1.1 b
Valuation ($)
7.3 m
Valuation ($)
36.4 m
Valuation ($)
97.9 m
Twitter followers
Twitter followers
N/A
Twitter followers
2.2 k
Twitter followers
N/A
Twitter followers
65
Twitter followers
N/A

Financial

Net income
Net income
($18.5m) (FY, 2017)
Net income
($10.6b) (FY, 2016)
Net income
N/A
Net income
($13m) (FY, 2017)
Net income
($34.7m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 7.2m
Total funding raised
N/A
Total funding raised
$ 4.8m
Total funding raised
N/A
Total funding raised
$ 7m
For sources of this data, please see the company profileDownload Excel

View company profiles

Intellia Therapeutics
HQ
Cambridge, US
Employees
104

Intellia is developing therapeutic products to help people with genetic diseases.

View company
Bioblast Pharma
HQ
Tel Aviv-Yafo, IL
Employees
12

Bioblast Pharma Ltd., a clinical-stage biotechnology company, develops therapies for patients with rare and ultra-rare genetic diseases.

View company
Vical
HQ
San Diego, US
Employees
73

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies.

View company
Aevi Genomic Medicine
HQ
Wayne, US
Employees
24

Aevi Genomic Medicine is focused on translating genetic discoveries into novel therapies to improve the lives of children and adults with pediatric onset life altering diseases.

View company